Effective on that date, its common stock now trades for quotation on the OTCQB, an electronic quotation service operated by OTC Markets Group Inc...The company expects that its common stock will also trade on the OTC Bulletin Board...Affymax will continue to trade under the symbol "AFFY

The company expects its common stock to begin trading on the NYSE market on June 17, under its current ticker symbol, "AMPE...In addition to the research collaboration, which includes three cancer targets, Isis and AstraZeneca are developing two antisense drugs, ISIS-ARRx and ISIS-STAT3RX, discovered by Isis and licensed to AstraZeneca for the treatment of cancer. (See BioWorld Today, Dec. 12, 2012...The company expects to enter a third agreement (separation agreement) governing other terms of the

Novavax said it plans to make a separate, private offer for outstanding stock options, issuing 218,120 shares of Novavax common stock, corresponding to a value of SEK 8.30 (US$1 .26) for each option share

Maxygen Inc., of Redwood City, Calif., said its board approved the liquidation and dissolution of the company, subject to shareholder approval, and plans to distribute all available cash to its shareholders after making reasonable provision for known and potential liabilities and other obligations of the company...Maxygen estimated that the aggregate amount of the initial liquidating distribution to stockholders will be between $68.2 million and $69.6 million, or between $2.45 to $2.50 per share

It was developed to block the action of orexins, neurotransmitters in a specific part of the brain that help to keep a person awake...Perrigo Co., of Allegan, Mich., is transferring the listing of its U.S.-traded common stock to the New York Stock Exchange (NYSE) from Nasdaq...The company expects to begin trading on the NYSE on June 6 under its current stock symbol "PRGO," and will continue to trade on Nasdaq until the transfer takes place

Also, it revises the proposal to decrease the total number of authorized shares of common stock, dropping the total number of authorized shares of common stock post-reverse stock split to 50 million shares (in the earlier proxy, Advaxis proposed a total number of 300 million shares of common stock post-reverse stock split...Another revised proposal to approve an amendment to the 2011 Omnibus Incentive Plan, calls for a limit to the amount of the requested increase to 75 million shares of common

to repurchase $5 billion of common stock...Under terms of the ASR, Merck agreed to an initial delivery of about 99.5 million shares based on current market prices

The court found that Emmaus had properly canceled all shares of its common stock held by AFH and that AFH and Heshmatpour must return to Emmaus all stock certificates representing the shares...to produce and supply 123I-labeled NAV5001 for Navidea's late-phase clinical trials...Compared to the placebo group, animals treated with WF10 showed a reduction of the degree of symptoms

The company plans to use proceeds to repurchase common stock and for general corporate purposes, including the repayment of outstanding commercial paper borrowings and upcoming debt maturities

Common stock in Fibrocell Science Inc., of Exton, Pa., has been approved for listing on the NYSE Market, to commence trading on May 17, under the ticker symbol FCSC

Kinnovata plans to develop, manufacture and commercialize respiratory products for China and other regional Asian markets, initially exploiting Vectura's Clickhaler and Duohaler dry powder inhaler (DPI) technology platforms in asthma and chronic obstructive pulmonary disease...KingYork is expected to hold a 50 percent equity share, with Vectura holding 35 percent and Zendex and partners holding 15 percent

The split is intended to increase the per-share trading price of the common stock to satisfy the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market

turned its attention to other candidates in its pipeline...The Carlsbad, Calif.-based company priced an underwritten public offering of 9 million shares of its common stock at $19 per share, seeking to raise $171 million from the offering, which is expected to close on or about May 14...continue to view shares as undervalued based on the >$1B potential of ISIS-SMN-Rx, as well as the promise of ISIS-TTR-Rx and Isis' 20+ other pipeline candidates," he wrote

He allegedly permitted a trader, dubbed John Doe in the affidavit, to purchase 20,000 shares of an initial public offering of stock for GeneMedicine Inc., of The Woodlands, Texas, in exchange for which John Doe agreed to purchase 5,000 shares of stock issued by two other companies, Hemisphere and Ecogen Inc...Public Information Officer Marvin Smilon, of the U.S. Attorney's Office, told BioWorld Today that a hearing is set for May 14 before Judge Kevin Thomas Duffy, in Manhattan District Court

StemCells issued SVB a warrant to purchase 293,531 shares of common stock at $1.7034 per share 4/10/13 Unigene Laboratories Inc. (Boonton, N.J.) Amended financing agreement N/A $0.75 Unigene entered a second amendment to a financing agreement with affiliates of Victory Park Capital Advisors LLC, whereby VPC agreed to purchase an additional $750,000 senior secured note convertible into shares of Unigene common stock 4/9/13 VistaGen Therapeutics Inc. (South San Francisco) Investment 72S $36

The company expects to repurchase about $7.5 billion of common stock over the next 12 months, financed through a combination of debt issuance and operating cash flows, with the remainder to be repurchased over time with no time limit

Soligenix also will issue 1 million shares of its common stock to Intrexon, representing 8.5 percent of its outstanding shares, and provide Intrexon with the right to participate in future offerings and to purchase the company's shares in the open market

26, 2017, at an interest rate of 13 percent, and the conversion rate will be re-priced from $3.78 to $1.25 per share of common stock...Due to third-party manufacturing issues, distribution of Janssen Products LP's Caelyx in Europe has been intermittently disrupted since 2011

BioMarin Pharmaceutical Inc., of San Rafael, Calif., said it submitted a marketing authorization application to the European Medicines Agency for Vimizim (BMN-110, elosulfase alfa), an enzyme replacement therapy for patients with rare lysosomal storage disorder mucopolysaccharidosis Type IVA, also called Morquio A syndrome...OvaScience, of Cambridge, Mass, said its common stock was approved for listing on Nasdaq under the ticker "OVAS" and will start trading April 30